Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: A cross sectional study

BMC Health Services Research

Volumn 8, Issue , 2008, Pages

  Meisinger, Christa ^a,b   Heier, Margit ^a,b   Landgraf, Rüdiger ^c   Happich, Michael ^d   Wichmann, H Erich ^a,c   Piehlmeier, Wolfgang ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; CROSS-SECTIONAL STUDY; GERMANY; HYPERLIPIDEMIA; HYPERTENSION; MIDDLE AGED; PREVALENCE; RISK; WAIST HIP RATIO;

AGED; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; WAIST-HIP RATIO;

EID: 58149104421     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-8-226     Document Type: Article

References (30)

1. Microalbuminuria: implications for micro- and macro-vascular disease. T Deckert A Kofoed-Enevoldsen K Norgaard K Borch-Johnsen B Feldt-Rasmussen T Jensen, Diabetes Care 1992 15 1181 1191 10.2337/diacare.15.9.1181 1396015
2. Nephropathy in type 2 diabetes. E Ritz, J Intern Med 1999 245 111 126 10.1046/j.1365-2796.1999.00411.x 10081514
3. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. AE Raine, Diabetologia 1993 36 1099 1104 10.1007/BF02374505 8243861
4. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. HH Parving MA Gall P Skott HE Jorgensen H Lokkegaard F Jorgensen B Nielsen S Larsen, Kidney Int 1992 41 758 762 10.1038/ki.1992.118 1513098
5. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). AI Adler RJ Stevens SE Manley RW Bilous CA Cull RR Holman, Kidney Int 2003 63 1 225 232 10.1046/j.1523-1755. 2003.00712.x 12472787
6. Predictors of mortality in insulin-dependent diabetes: 10-year observational follow-up study. P Rossing, BMJ 1996 313 779 784 8842069
7. Progression of nephropathy in type 2 diabetic patients. K Rossing PK Christensen P Hovind L Tarnow P Rossing HH Parving, Kidney Int 2004 66 1596 1605 10.1111/j.1523-1755.2004.00925.x 15458456
8. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. A Mohanram Z Zhang S Shahinfar WF Keane BM Brenner RD Toto, Kidney Int 2004 66 1131 1138 10.1111/j.1523-1755.2004.00863.x 15327408
9. Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg Diabetes Family Study. B Kuch W von Scheidt W Peter A Döring W Piehlmeier R Landgraf C Meisinger, Diabetes Care 2007 30 946 952 10.2337/dc06-2123 17392555
10. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. AS Levey J Coresh E Balk AT Kausz A Levin MW Steffes RJ Hogg RD Perrone J Lau G Eknoyan, Ann Intern Med 2003 139 137 147 12859163
11. Guidelines for the management of arterial hypertension. European Society of Hypertension-European Society of Cardiology Guidelines Committee, J Hypertens 2003 21 1011 1053 10.1097/00004872-200306000-00001 12777938
12. Standards of medical care in diabetes. American Diabetes Association, Diabetes Care 2005 28 S4 S36 10.2337/diacare.28.suppl_1.S4 15618112
13. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr EJ Roccella, Hypertension 2003 42 1206 1252 10.1161/01.HYP.0000107251.49515.c2 14656957
14. Diabetes mellitus in Egypt: Glycaemic control of microvascular and neuropathic complications. WH Herman RE Aubert MM Engelgau TJ Thompson MA Ali ES Sous M Hegazy A Badran SJ Kenny EW Gunter AM Malarcher RJ Brechner SF Wetterhall F DeStefano PJ Smith M Habib S abd el Shakour AS Ibrahim EM el Behairy, Diabet Med 1998 15 1045 1051 10.1002/(SICI)1096-9136(1998120)15: 12<1045::AID-DIA696>3.0.CO;2-L 9868980
15. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. G Bruno P Cavallo-Perin G Bargero M Borra V Calvi N D'Errico P Deambrogio G Pagano, Diabetes Care 1996 19 43 47 10.2337/diacare.19.1.43 8720532
16. Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. AX Garg BA Kiberd WF Clark RB Haynes CM Clase, Kidney Int 2002 61 2165 2175 10.1046/j.1523-1755.2002.00356.x 12028457
17. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). RJ Tapp JE Shaw PZ Zimmet B Balkau SJ Chadban AM Tonkin TA Welborn RC Atkins, Am J Kidney Dis 2004 44 792 798 10.1016/S0272-6386(04)01079-0 15492944
18. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area. E Standl H Stiegler, Diabetologia 1993 36 10 1017 1020 10.1007/BF02374493 8243849
19. Screening of diabetic patients for microalbuminuria in primary care - The PROSIT-Project. Proteinuria Screening and intervention. W Piehlmeier R Renner W Schramm T Kimmerling S Garbe R Proetzsch J Fahn K Piwernetz R Landgraf, Exp Clin Endocrinol Diabetes 1999 107 4 244 251 10433063
20. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. A Varghese R Deepa M Rema V Mohan, Postgrad Med J 2001 77 399 402 11375456 10.1136/pmj.77.908.399
21. Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. G Gambaro G Bax M Fusaro M Normanno SM Manani M Zanella A Dangelo D Fedele S Favaro, Diabetes Nutr Metab 2001 14 337 342 11853366
22. Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). JC Chan CK Cheung R Swaminathan MG Nicholls CS Cockram, Postgrad Med J 1993 69 204 210 8497435
23. Evaluation of risk factors for development of complications in Type II diabetes in Europe. A Liebl M Mata E Eschwège, Diabetologia 2002 45 S23 S28 10.1007/s00125-002-0874-x 12136408
24. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes : UKPDS 38. UK Prospective Diabetes Study Group, BMJ 1998 317 703 713 9732337
25. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. L Hansson A Zanchetti SG Carruthers B Dahlöf D Elmfeldt S Julius J Menard KH Rahn H Wedel S Westerling, Lancet 1998 351 1755 1762 10.1016/S0140-6736(98)04311-6 9635947
26. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). K Pyorala TR Pedersen J Kjekshus O Faergeman AG Olsson G Thorgeirsson, Diabetes Care 1997 20 614 620 10.2337/diacare.20.4.614 9096989
27. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. P Gaede P Vedel N Larsen GV Jensen HH Parving O Pedersen, N Engl J Med 2003 348 5 383 393 10.1056/NEJMoa021778 12556541
28. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. SH Saydah J Fradkin CC Cowie, JAMA 2004 291 335 342 10.1001/jama.291.3.335 14734596
29. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. G Charpentier N Genès L Vaur J Amar P Clerson JP Cambou P Gueret ESPOIR Diabetes Study Investigators, Diabetes Metab 2003 29 152 158 10.1016/S1262-3636(07)70022-8 12746636
30. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. SJ Beaton SS Nag MJ Gunter JM Gleeson SS Sajjan CM Alexander, Diabetes Care 2004 27 694 698 10.2337/diacare.27.3.694 14988287